The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma

BACKGROUND: The application of VEGF signaling inhibitors have been associated with more invasive or metastatic behavior of cancers including hepatocellular carcinoma (HCC). We explored the contribution of MET pathway to the enhanced HCC invasion and metastasis by VEGF signaling inhibition, and inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu, Gao, Xiaomei, Zhu, Ying, Kadel, Dhruba, Sun, Haoran, Chen, Jing, Luo, Qin, Sun, Haoting, Yang, Luyu, Yang, Jing, Sheng, Yuanyuan, Zheng, Yan, Zhu, Kejin, Dong, Qiongzhu, Qin, Lunxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925844/
https://www.ncbi.nlm.nih.gov/pubmed/29712569
http://dx.doi.org/10.1186/s13046-018-0750-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925844/
https://www.ncbi.nlm.nih.gov/pubmed/29712569
http://dx.doi.org/10.1186/s13046-018-0750-2

Ejemplares similares